The rational design of atomic‐scale interfaces in multiphase nanohybrids is an alluring and challenging approach to develop advanced electrocatalysts. Herein, through the selection of two different metal oxides with particular intrinsic features, advanced Co3O4/CeO2 nanohybrids (NHs) with CeO2 nanocubes anchored on Co3O4 nanosheets are developed, which show not only high oxygen vacancy concentration but also remarkable 2D electron gas (2DEG) behavior with ≈0.79 ± 0.1 excess e−/u.c. on the Ce3+ sites at the Co3O4–CeO2 interface. Such a 2DEG transport channel leads to a high carrier density of 3.8 × 1014 cm−2 and good conductivity. Consequently, the Co3O4/CeO2 NHs demonstrate dramatically enhanced oxygen evolution reaction (OER) performances with a low overpotential of 270 mV at 10 mA cm−2 and a high turnover frequency of 0.25 s−1 when compared to those of pure Co3O4 and CeO2 counterparts, outperforming commercial IrO2 and some recently reported representative OER catalysts. These results demonstrate the validity of tailoring the electrocatalytic properties of metal oxides by 2DEG engineering, offering a step forward in the design of advanced hybrid nanostructures.
By cutting MoS2 microcrystals to quantum dots (QDs) of sizes below 10 nm, the photoluminescence (PL) at ca. 450 nm can be detected easily due to the quantum confinement effects across the 2D planes. The PL is stable under continuous irradiation of UV light but gradually quenches when treated with an increasing concentration of hydrogen peroxide. Time-resolved PL and Raman spectra imply that H2O2 causes the partial oxidation of MoS2 QDs. First-principles calculations reveal that the MoS2 QDs with oxygen impurity are of indirect bandgap structures showing no notable PL. And absorption spectra verify that the PL of MoS2 QDs quenched by H2O2 is attributed to the oxidation. The integrated PL intensity and H2O2 concentration show an exponential relationship in the range of 2–20 μM, suggesting that MoS2 QDs are potential fluorescent probes for hydrogen peroxide sensing in a physiological environment.
Background Abnormalities of lymphocyte subsets and cytokine profiles have been observed in most patients with coronavirus disease (COVID-19). Here, we explore the role of lymphocyte subsets and cytokines on hospital admission in predicting the severity of COVID-19. Methods This study included 214 patients with COVID-19 who were treated at Chongqing University Three Gorges Hospital from January 19, 2020 to April 30, 2020. Any mutants were not detected in the studied patients. Patients were divided into non-intensive care unit (ICU) (mild/moderate) group and ICU (severe/critical) group, according to the severity of the disease. Clinical and laboratory data, including peripheral lymphocyte subsets and cytokines, were analyzed and compared. Logistic regression was used to analyze the predictive factors for ICU admission. Receiver operating characteristic (ROC) curves were drawn to evaluate the predictive value of selected indicators for the severity of COVID-19. Results Of the 214 patients enrolled, 161 were non-ICU patients and 53 were ICU patients. Lymphopenia was observed in nearly all of ICU patients (96.2%) and 84.5% of non-ICU patients on hospital admission. The absolute number of lymphocytes, CD3+ T cells, CD4+ T cells, CD8+ T cells, CD19+ B cells, and natural killer (NK) cells were lower in ICU group (659.00 × 106/L, 417.00 × 106/L, 261.00 × 106/L, 140.00 × 106/L, 109.00 × 106/L, 102.00 × 106/L, respectively) than in non-ICU group (1063.00 × 109/L, 717.00 × 106/L, 432.00 × 106/L, 271.00 × 106/L, 133.00 × 106/L, 143.00 × 106/L, respectively). Interleukin (IL)-6 was significantly higher in ICU patients than in non-ICU patients (18.08 pg/mL vs. 3.13 pg/mL, P < 0.001). Multivariate logistic regression analysis showed that age (odds ratio: 1.067 [1.034–1.101]), diabetes mellitus (odds ratio: 9.154 [2.710–30.926]), CD3+ T cells (odds ratio: 0.996 [0.994–0.997]), and IL-6 (odds ratio: 1.006 [1.000–1.013]) were independent predictors for the development of severe disease. ROC curve analysis showed that the area under the ROC curve (AUC) of CD3+ T cells and IL-6 was 0.806 (0.737–0.874) and 0.785 (0.705–0.864), respectively, and the cutoff values were 510.50 × 106/L (sensitivity, 71.7%; specificity, 79.5%) and 6.58 pg/mL (77.4%, 74.5%), respectively. There were no statistical differences among all tested indicators of lymphocyte subsets and cytokines between severe group (n = 38) and critical group (n = 15) on hospital admission or ICU admission, respectively. Conclusions The levels of lymphocyte subsets decreased and the level of IL-6 increased significantly in ICU COVID-19 patients compared with non-ICU COVID-19 patients. Therefore, the number of CD3+ T cells and the level of IL-6 on hospital admission may serve as predictive factors for identifying patients with wild-type virus infection who will have severe disease.
Photothermal and magnetothermal effects are promising in hyperthermia for cancer therapy. However, the development of safe treatments with limited side-effects requires a relatively-high thermal efficiency triggered by mild near-infrared (NIR) light and alternating magnetic field (HAC), which remains a formidable challenge. In this work, a magnetic field enhanced photothermal effect (MFEP) of Fe3O4 nanoparticles is proposed and investigated systematically. The results suggest remarkable temperature increments of 9.59 to 36.90 °C under irradiation of NIR with different light power densities (808 nm, 0–6.98 W/cm2) combined with a certain magnetic field (HAC = 1.5 kA/m at 90 kHz). The rise of temperature induced by MFEP is substantially larger than the sum of isolated photothermal and magnetothermal effects, which is attributed to the hot-phonon bottleneck effect. The MFEP of Fe3O4 nanoparticles could serve as an effective treatment for cancer therapy in the future.
In this work, we experimentally investigated the thermal stability of the interlayer exchange coupling field (H ex ) and strength (−J iec ) in synthetic antiferromagnetic (SAF) structure of [Pt(0.6)/Co(0.6)] 2 /Ru(t Ru )/[Co(0.6)/Pt(0.6)] 4 multilayers with perpendicular anisotropy. Depending on the thickness of the spacing ruthenium (Ru) layer, the observed interlayer exchange coupling can be either ferromagnetic or antiferromagnetic. The H ex were studied by measuring the magnetization hysteresis loops in the temperature range from 100 K to 700 K as well as the theoretical calculation of the −J iec . It is found that the interlayer coupling in the multilayers is very sensitive to the thickness of Ru and temperature. The H ex exhibits either a linear or a non-linear dependence on the temperature for different thickness of Ru. Furthermore, our SAF multilayers show a high thermal stability even up to 600 K (H ex = 3.19 kOe, −J iec = 1.97 erg/cm 2 for t Ru = 0.6 nm, the unit 1 Oe = 79.5775 A·m −1 ), which was higher than the previous studies.
Ultraviolet (UV) light can be used in versatile applications ranging from photoelectronic devices to biomedical imaging. In the development of new UV light sources, in this study, stable UV emission at ≈350 nm is unprecedentedly obtained from carbon nanospheres (CNSs). The origin of the UV fluorescence is comprehensively investigated via various characterization methods, including Raman and Fourier transform infrared analyses, with comparison to the visible emission of carbon nanodots. Based on the density functional calculations, the UV fluorescence is assigned to the carbon nanostructures bonded to bridging O atoms and dangling -OH groups. Moreover, a twofold enhancement in the UV emission is acquired for Au-carbon core-shell nanospheres (Au-CNSs). This remarkable modification of the UV emission is primarily ascribed to charge transfer between the CNSs and the Au surface.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.